6550-- Ventena Contract Request

Description

{"description":"Special Notice Notice of Intent to Award a Sole Source Procurement \n\nThe Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract to Roche Diagnostics Corporation for procurement of the following reagents and consumable supplies: \n\nEstimated Annual Quantities\n\nItem Description\nItem Number\nQuantity\n1\nReagent, DAB Detection\n760-500\n25\n2\nReagent, Stainer, Amplification \n760-080\n20\n3\nReagent, Stainer, Reaction Buffer\n950-300\n40\n4\nReagent, Hematoxylin\n760-2021\n26\n5\nReagent, Bluing Agent\n760-2037\n26\n6\nStaining Solution, Protease\n760-2018\n7\n7\n10x EZ Stainer, Prep Solution, 2L\n950-102\n15\n8\nBenchmark Ultra LCS\n650-210\n80\n9\nSolution, Ultra, Cell CC1\n950-224\n14\n10\nControl, Negative Monoclonal\n760-2014\n6\n11\nElastin Van Gieson Kit 50 Test\nCat. 09592229001\n6\n12\nStaining Kit, Complex Stains, Reticulum II\n860-024\n4\n13\nStaining Kit, Complex Stains, Special \n860-028\n4\n14\nDEPAR Solution, BMK Special Stains\n860-036\n6\n15\nLiquid Coverslip, BMK Special Stains\n860-034\n10\n16\nBenchmark Special Stains Wash II\nCatalog 08309817001\n8\n17\nBenchmark Special Stains I Cleaning Kit\n860-049\n7\n18\nVentana H. Pylori (SP48) PAB\n790-1014\n24\n19\nCONFIRM ANTI-THRYOID TRANSCRIPTION FACT \n\n790-4398\n8\n20\nRibbon, Ebar Printer \n1632900\n3\n21\nKit Pack Ebar\n1418702\n5\n22\nConfirm Cytokeratin7 Rabbitmono\n790-4462\n8\n23\nAntibody KI 67 (30-9) Rabbit Monoclonal\n790-4286\n8\n24\nS IHC ANTIBODY ROUTINE: CONFIRM ANTI-S100 (POLYCLONAL) PAB\n760-2523\n6\n25\n CONFIRM CYTOKERATIN 20 RABBIT MONO \n790-4554\n10\n26\nCONFIRM CYTOKERATIN 20 RABBIT MONO\n\n790-4431\n6\n27\nANTI-CHROMOGRANIN A (LK2H10) PAB \n760-2519\n4\n28\nCONFIRM CYTOKERATIN 20 RABBIT MONO \n790-7061\n4\n29\nCD-138 (B-A38) PAB, CELL MARQUE\n790-4248\n4\n30\nCONFIRM ANTI-CD34 (QBEND/10) PRIMARY ANTIBODY \n790-2927\n4\n31\nCONFIRM ANTI-CD3 (2GV6) RABBIT MONOCLONAL \n\n790-4341\n4\n32\nCONFIRM ANTI-CD5 (SP19) RABBIT MONO \n\n790-4451\n4\n33\nCONFIRM ANTI-CD20 (L26) PAB \n\n760-2531\n4\n34\nCD68 (SP251V18) RABBIT MONOCLONAL AB \n\n790-7248\n4\n35\nVENTANA ANTI-CD10 (SP67) \n\n790-4506\n4\n36\nCONFIRM ANTI-SYNAPTOPHYSIN (SP11) RABBIT \n\n790-4407\n4\n37\nCYTOKERATIN (CAM 5.2) PAB\n790-4555\n4\n38\nIHC ANCILLARY, HEMATOXYLIN II \n\n790-2208\n2\n39\nIHC ANCILLARIES, OPTIVIEW AMPLIFICATION KIT \n\n760-099\n2\n40\n IHC ANCILLARIES: OPTIVIEW DAB DETECTION\n KIT (250) \n\n760-700\n2\n\nThe requested items will be used on the Ventana BenchMark Ultra system. The requesting activity states that the government owns and operates a Ventana BenchMark Ultra System and that the requested reagents and consumable supplies are the only supplies compatible with the instrument. A sole source letter from Roche states that all Ventana detection reagents, ancillaries, antibodies and probes are developed and validated for exclusive use on the fully automated Ventana Benchmark IHC/ISH slide staining system and cannot be substituted. The proposed order will be considered a standing order; where, the supplies will be ordered throughout the period of performance, on an as-needed basis. Network Contracting Office 17 will request the acquisition of these supplies from Roche on an IDIQ contract with a five-year ordering period. \n\nThis notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 5 days from the publication of this notice, a contract/order will be issued to Roche Diagnostics Corporation without any further notice.\n\nThe proposed contract actions are for supplies, which the government intends to negotiate with only one source. The anticipated statutory authorities permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. \n\nThe proposed sole source procurement will be made by an open market pricing agreement with Roche Diagnostics Corporation. \n\n"} Solicitation Number: 36C25726Q0105 Type: Special Notice Base Type: Special Notice NAICS: 325413 Classification Code: 6550 Response Deadline: 2026-02-09T10:00:00-06:00 Office Address: San Antonio, TX POC: Susan Flores, Susan.flores2@va.gov, (210) 694-6227 {"description":"Special Notice Notice of Intent to Award a Sole Source Procurement \n\nThe Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract to Roche Diagnostics Corporation for procurement of the following reagents and consumable supplies: \n\nEstimated Annual Quantities\n\nItem Description\nItem Number\nQuantity\n1\nReagent, DAB Detection\n760-500\n25\n2\nReagent, Stainer, Amplification \n760-080\n20\n3\nReagent, Stainer, Reaction Buffer\n950-300\n40\n4\nReagent, Hematoxylin\n760-2021\n26\n5\nReagent, Bluing Agent\n760-2037\n26\n6\nStaining Solution, Protease\n760-2018\n7\n7\n10x EZ Stainer, Prep Solution, 2L\n950-102\n15\n8\nBenchmark Ultra LCS\n650-210\n80\n9\nSolution, Ultra, Cell CC1\n950-224\n14\n10\nControl, Negative Monoclonal\n760-2014\n6\n11\nElastin Van Gieson Kit 50 Test\nCat. 09592229001\n6\n12\nStaining Kit, Complex Stains, Reticulum II\n860-024\n4\n13\nStaining Kit, Complex Stains, Special \n860-028\n4\n14\nDEPAR Solution, BMK Special Stains\n860-036\n6\n15\nLiquid Coverslip, BMK Special Stains\n860-034\n10\n16\nBenchmark Special Stains Wash II\nCatalog 08309817001\n8\n17\nBenchmark Special Stains I Cleaning Kit\n860-049\n7\n18\nVentana H. Pylori (SP48) PAB\n790-1014\n24\n19\nCONFIRM ANTI-THRYOID TRANSCRIPTION FACT \n\n790-4398\n8\n20\nRibbon, Ebar Printer \n1632900\n3\n21\nKit Pack Ebar\n1418702\n5\n22\nConfirm Cytokeratin7 Rabbitmono\n790-4462\n8\n23\nAntibody KI 67 (30-9) Rabbit Monoclonal\n790-4286\n8\n24\nS IHC ANTIBODY ROUTINE: CONFIRM ANTI-S100 (POLYCLONAL) PAB\n760-2523\n6\n25\n CONFIRM CYTOKERATIN 20 RABBIT MONO \n790-4554\n10\n26\nCONFIRM CYTOKERATIN 20 RABBIT MONO\n\n790-4431\n6\n27\nANTI-CHROMOGRANIN A (LK2H10) PAB \n760-2519\n4\n28\nCONFIRM CYTOKERATIN 20 RABBIT MONO \n790-7061\n4\n29\nCD-138 (B-A38) PAB, CELL MARQUE\n790-4248\n4\n30\nCONFIRM ANTI-CD34 (QBEND/10) PRIMARY ANTIBODY \n790-2927\n4\n31\nCONFIRM ANTI-CD3 (2GV6) RABBIT MONOCLONAL \n\n790-4341\n4\n32\nCONFIRM ANTI-CD5 (SP19) RABBIT MONO \n\n790-4451\n4\n33\nCONFIRM ANTI-CD20 (L26) PAB \n\n760-2531\n4\n34\nCD68 (SP251V18) RABBIT MONOCLONAL AB \n\n790-7248\n4\n35\nVENTANA ANTI-CD10 (SP67) \n\n790-4506\n4\n36\nCONFIRM ANTI-SYNAPTOPHYSIN (SP11) RABBIT \n\n790-4407\n4\n37\nCYTOKERATIN (CAM 5.2) PAB\n790-4555\n4\n38\nIHC ANCILLARY, HEMATOXYLIN II \n\n790-2208\n2\n39\nIHC ANCILLARIES, OPTIVIEW AMPLIFICATION KIT \n\n760-099\n2\n40\n IHC ANCILLARIES: OPTIVIEW DAB DETECTION\n KIT (250) \n\n760-700\n2\n\nThe requested items will be used on the Ventana BenchMark Ultra system. The requesting activity states that the government owns and operates a Ventana BenchMark Ultra System and that the requested reagents and consumable supplies are the only supplies compatible with the instrument. A sole source letter from Roche states that all Ventana detection reagents, ancillaries, antibodies and probes are developed and validated for exclusive use on the fully automated Ventana Benchmark IHC/ISH slide staining system and cannot be substituted. The proposed order will be considered a standing order; where, the supplies will be ordered throughout the period of performance, on an as-needed basis. Network Contracting Office 17 will request the acquisition of these supplies from Roche on an IDIQ contract with a five-year ordering period. \n\nThis notice is not to be considered a request for quotations or proposals. A contract will not be awarded based on an offer received in response to this notice; however, all responsible sources may submit a capability statement, proposal or quotation, which shall be considered by the agency. Proposals or offers received will be used to determine if a comparable source is available and more advantageous to the government. If no affirmative written response is received within 5 days from the publication of this notice, a contract/order will be issued to Roche Diagnostics Corporation without any further notice.\n\nThe proposed contract actions are for supplies, which the government intends to negotiate with only one source. The anticipated statutory authorities permitting other than full and open competition for the requirement is 41 U.S.C. 3304(a)(1), as implemented by FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. \n\nThe proposed sole source procurement will be made by an open market pricing agreement with Roche Diagnostics Corporation. \n\n"}